Updates from LND Therapeutics.
The latest program milestones, publications, and partnership announcements from our clinical network.
Poop pill could be breakthrough for cancer with only 10% survival rate
New York Post covers emerging microbiome capsule research as a potential breakthrough for advanced cancers.
Read the article →World’s first trial studies ‘poop pills’ for advanced pancreatic cancer treatment
CTV News reports on a world-first study in London, Ontario evaluating fecal microbiota transplant capsules alongside chemotherapy for advanced pancreatic cancer.
Read the CTV story →‘Poop pill’ could be breakthrough for pancreatic cancer with ~10% five‑year survival rate
New York Post covers Canadian researchers studying an oral fecal microbiota capsule approach for advanced pancreatic cancer.
Read the NY Post story →Can fecal transplants improve treatments for deadly cancer?
CTV News explores whether fecal microbiota transplantation can enhance treatment response in aggressive cancers.
Read the CTV story →New study will assess fecal transplants in treatment of pancreatic cancer
Research news release describing a multi-stage program evaluating fecal microbiota transplant approaches in advanced pancreatic cancer.
Read the release →Could A Healthy Gut Make You More Responsive To Cancer Treatment?
Popular media coverage discussing the gut microbiome’s relationship to cancer treatment response.
Request link →Could Poop Be The Next Treatment For Cancer?
Mainstream coverage discussing fecal microbiota transplants as a potential adjunct in cancer care.
Request link →Could microorganisms in poop help treat the deadliest form of skin cancer?
EurekAlert news release on a Phase I trial combining fecal transplants and immunotherapy for melanoma.
Read the release →London cancer researchers make number 2 their number 1 priority
Coverage highlighting microbiome research exploring fecal transplant approaches in melanoma.
Request link →London team first in Canada to test fecal transplants for cancer treatment
Coverage of a Canadian-first clinical study evaluating fecal transplants alongside cancer treatment.
Read story →Microorganisms in poop may help treat the deadliest form of skin cancer
International media highlight studies examining how gut microbes may influence melanoma treatment outcomes.
Read coverage →Researchers seeking poop donors for skin cancer treatment study
Canadian researchers recruit healthy donors to support fecal transplant studies in melanoma patients.
Read coverage →Researchers seeking poop donors for skin cancer treatment study
Coverage of recruitment efforts for a melanoma study involving fecal microbiota transplant approaches.
Request link →Why fecal transplants could be the next frontier in fighting skin cancer
Multiple outlets report on early melanoma research investigating fecal microbiota transplantation.
Read coverage →Why fecal transplants could be the next frontier in fighting skin cancer
Coverage of early work exploring fecal microbiota transplants to improve melanoma treatment response.
Read story →Selected publications
Peer-reviewed evidence and key clinical research.
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Phase I study combining healthy-donor FMT with anti-PD-1 therapy in advanced melanoma, reporting safety and clinical/microbiome outcomes.
Read paper →Need the full news archive?
Contact our partnerships team for press materials, publication briefings, and data-sharing agreements.
Available resources
- Press releases and milestone summaries.
- Publication briefs and clinical highlights.
- Partner onboarding guides for new sites.